Swiss drugmaker betting on cholesterol-lowering prospect
Eyecare business had been problematic since Novartis bought it for $52 billion in 2011
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices